News

Categories

Class IIa

Skin Analytics achieves Class IIa UKCA Mark for DERM. The UK’s first and only Class IIa certified AI dermatology device

Now a Class IIa medical device, DERM, uses machine learning algorithms to recognise the most common malignant, pre-malignant and benign skin lesions, including melanoma – the fifth most common cancer in the UK. Using a decade’s worth of research and development on skin lesions, it is designed to accelerate patient diagnosis and relieve pressure on the healthcare system. 

Read More
NHSX

Skin Analytics Receives NHSX Award for AI-Based Skin Cancer Tool

Created to accelerate the evaluation of Artificial Intelligence (AI) technologies within the NHS, the NHSX award is highly competitive and prestigious, with an extensive evaluation process. Being granted the award is a major validation of what we do at Skin Analytics and the effort we have put in to build strong foundations based on clinical evidence, regulatory rigor and proprietary AI. 

Read More
Skin Analytics Awarded ISO 13485 Certification

Skin Analytics Awarded ISO 13485 Certification

ISO 13485:2016 is an internationally recognised quality standard for medical devices and is a pre-requisite for registration as a class II medical device under the MDR. This accreditation represents another important milestone for the company and our mission to help more people survive skin cancer. 

Read More
CNN

Skin Analytics on CNN

Having CNN come out and spend time with us was very exciting, if a little nerve racking. They asked us some very insightful questions and I believe that we responded with some well thought out answers.

Read More
AI Standards for Healthcare

AI Standards for Healthcare

The last thing we want to see is innovation being suppressed under volumes of red tape. At the same time, we’re trying to change healthcare, meaning that we’re dealing with people’s health and that’s not an area to “move fast and break things” for fairly obvious reasons.

Read More

Subscribe to our news updates

We won't spam
you, we promise.